Evidence map›Paper›PMID 26231518›Full record

ArticleBMC genomics2015

MAC: identifying and correcting annotation for multi-nucleotide variations.

Lei Wei, Lu T Liu, Jacob R Conroy, Qiang Hu, Jeffrey M Conroy, Carl D Morrison, Candace S Johnson, Jianmin Wang, Song Liu

Abstract read
In one paragraph

Article in BMC genomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lei WeiDepartment of Biostatistics & Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY, USA. Lei.Wei@RoswellPark.org.
Lu T LiuCenter for Personalized Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA. Lu.Liu@RoswellPark.org.
Jacob R ConroyCenter for Personalized Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA. jrc63@duke.edu.
Qiang HuDepartment of Biostatistics & Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY, USA. Qiang.Hu@RoswellPark.org.
Jeffrey M ConroyCenter for Personalized Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA. Jeffrey.Conroy@RoswellPark.org.
Carl D MorrisonCenter for Personalized Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA. Carl.Morrison@RoswellPark.org.
Candace S JohnsonDepartment of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA. Candace.Johnson@RoswellPark.org.
Jianmin WangDepartment of Biostatistics & Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY, USA. Jianmin.Wang@RoswellPark.org.
Song LiuDepartment of Biostatistics & Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY, USA. Song.Liu@RoswellPark.org.

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
NCI NIH HHS P30 CA016056
6 · The paper itself

Abstract

backgroundNext-Generation Sequencing (NGS) technologies have rapidly advanced our understanding of human variation in cancer. To accurately translate the raw sequencing data into practical knowledge, annotation tools, algorithms and pipelines must be developed that keep pace with the rapidly evolving technology. Currently, a challenge exists in accurately annotating multi-nucleotide variants (MNVs). These tandem substitutions, when affecting multiple nucleotides within a single protein codon of a gene, result in a translated amino acid involving all nucleotides in that codon. Most existing variant callers report a MNV as individual single-nucleotide variants (SNVs), often resulting in multiple triplet codon sequences and incorrect amino acid predictions. To correct potentially misannotated MNVs among reported SNVs, a primary challenge resides in haplotype phasing which is to determine whether the neighboring SNVs are co-located on the same chromosome.

resultsHere we describe MAC (Multi-Nucleotide Variant Annotation Corrector), an integrative pipeline developed to correct potentially mis-annotated MNVs. MAC was designed as an application that only requires a SNV file and the matching BAM file as data inputs. Using an example data set containing 3024 SNVs and the corresponding whole-genome sequencing BAM files, we show that MAC identified eight potentially mis-annotated SNVs, and accurately updated the amino acid predictions for seven of the variant calls.

conclusionsMAC can identify and correct amino acid predictions that result from MNVs affecting multiple nucleotides within a single protein codon, which cannot be handled by most existing SNV-based variant pipelines. The MAC software is freely available and represents a useful tool for the accurate translation of genomic sequence to protein function.

Indexed as

Genome, HumanMolecular Sequence AnnotationHigh-Throughput Nucleotide SequencingHumansNeoplasmsPolymorphism, Single Nucleotide

Identifiers

PMID26231518
PMCPMC4521406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.